number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide GLP-1 prescription trends through June Eli Lilly's growth tied to

Reduced Risk of Obesity-Related Conditions : Losing weight can reduce the risk of diabetes, heart disease, and joint issues that become more common with age

Market Impact and Demand Elasticity Indicators Negative values indicate declining demand, positive values indicate increasing demand

Powerman Policies We add value to the lives of people, we share in the development of the countries where we work

Wilding, A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

Preservation of Insulin and Glucose Homeostasis Unlike growth hormone, which can cause insulin resistance and elevated blood glucose (diabetogenic effects), AOD-9604 has demonstrated no negative effects on carbohydrate metabolism

Irianto, J., Xia, Y., Pfeifer, C